Ascorbic acid 100mg tablets

Pays: Royaume-Uni

Langue: anglais

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingrédients actifs:

Ascorbic acid

Disponible depuis:

Healthcare Pharma Ltd

Code ATC:

A11GA01

DCI (Dénomination commune internationale):

Ascorbic acid

Dosage:

100mg

forme pharmaceutique:

Oral tablet

Mode d'administration:

Oral

classe:

No Controlled Drug Status

Type d'ordonnance:

Valid as a prescribable product

Descriptif du produit:

BNF: 09060301; GTIN: 5060013770357

Notice patient

F.TO STESO 140X340 MM - F.TO PIEGATO 140X28
F.TO STESO 140X340 MM - F.TO PIEGATO 140X28
PACKAGE LEAFLET: INFORMATION FOR THE USER
Ascorbic Acid 500mg, 200mg,
100mg and 50mg Tablets
(Ascorbic acid)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
!
Keep this leaflet. You may need to read
it again.
!
If you have any further questions, ask
your doctor or pharmacist.
!
This medicine has been prescribed for
you only. Do not pass it on to others. It
may harm them, even if their signs of
illness are the same as yours.
!
If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this
leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ascorbic Acid Tablets are and
what they are used for
2.
What you need to know before you take
Ascorbic Acid Tablets
3.
How to take Ascorbic Acid Tablets
4.
Possible side effects
5.
How to store Ascorbic Acid Tablets
6.
Contents
of
the
pack
and
other
information
Ascorbic
Acid
Tablets
contain
ascorbic
acid. Ascorbic acid is a form of vitamin C. It
is used as a supplement for the prevention
and treatment of scurvy.
DO NOT TAKE ASCORBIC ACID TABLETS IF:
!
You are allergic to Ascorbic Acid or any
of the other ingredients of this medicine
(listed in section 6).
!
You
suffer
from
hyperoxaluria
(excretion
of
urine
containing
large
amounts of calcium oxalate crystals).
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before
taking Ascorbic Acid Tablets:
!
If you are to undergo any blood or urine
tests as ascorbic acid can interfere with
some blood and urine tests.
!
If you are a regular smoker.
!
If you have kidney failure as ascorbic
acid enhances aluminium absorption
(present in antacids) which may reach
toxic levels.
OTHER
MEDICINES
AND
ASCORBIC
ACID
TABLETS
Tell your doctor or pharmacist if you are
taking, have recently taken or might take
any other medicines.
This is particularly important if you are
taking any of the following:
!
Amphetamines.
!
Co

Résumé des caractéristiques du produit

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid 100 mg Tablets.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Ascorbic Acid 100mg
Excipients with known effect:
Each tablet contains 147.2mg lactose and 8.1mg sucrose
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet.
White uncoated bi-convex tablets with tablet markings “100”.
4.1
THERAPEUTIC INDICATIONS
For the treatment of Vitamin C deficiency including the treatment and
prevention of scurvy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults and children over 4 years:
Prevention: 25 to 75 mg daily.
Treatment: Not less than 250 mg daily in divided doses.
Maximum daily doses:
Adults and children over 12 years, 1000 mg.
Children 4 – 11 years, 500 mg.
The elderly:
As for adults. As the dietary intake of vitamin C may be less in the
elderly,
they are at greater risk of being deficient in this vitamin.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Hypersensitivity to ascorbic acid or to any of the excipients listed
in section 6.1.
Ascorbic acid should not be given to patients with hyperoxaluria.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Increased intake of ascorbic acid over a prolonged period may result
in an
increased renal clearance of ascorbic acid, and deficiency may result
if the
intake is reduced or withdrawn rapidly (see section 4.8).
Ascorbic acid may interfere with tests and assays for urinary glucose,
giving
false negative results with methods utilising glucose oxidase with
indicator
(e.g. Labstix, Tes-tape) and false positive results with neocuproin
methods.
Estimation of uric acid by phosphotungstate or by uricase with copper
reduction and measurement of creatinine in non-deproteinised serum may
also
be affected.
High doses of ascorbic acid may give false negative readings in faecal
occult
blood tests.
Patients with rare hereditary problems of fructose or galactose
intolerance, total
lactase deficiency, glucose-galactose malabsorption o